SG3 MANAGEMENT, LLC – Apellis Pharmaceuticals, Inc. Transaction History
SG3 MANAGEMENT, LLC portfolio value:
$0
portfolio value
Apellis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | put | 0.00% | 0 shares | 1.23M | $68.3 | 53.4K | |
| Q3 2022 | call | Decrease | -100.00% | -50K shares | -2.26M | $68.3 | 0 |
| Q3 2022 | share | Increase | +3363.20% | 38.84K shares | 2.68M | $68.3 | 40K |
| Q2 2022 | call | Decrease | -50.00% | -50K shares | -2.82M | $45.22 | 50K |
| Q2 2022 | share | Increase | 0.00% | 1.15K shares | 52K | $45.22 | 1.15K |
| Q2 2022 | put | 0.00% | 0 shares | -298K | $45.22 | 53.4K | |
| Q1 2022 | call | Increase | 0.00% | 100K shares | 5.08M | $50.81 | 100K |
| Q1 2022 | put | Increase | 0.00% | 53.4K shares | 2.71M | $50.81 | 53.4K |
| Q4 2021 | share | Decrease | -100.00% | -100K shares | -3.29M | $47.95 | 0 |
| Q4 2021 | put | Decrease | -100.00% | -291.1K shares | -9.59M | $47.95 | 0 |
| Q4 2021 | call | Decrease | -100.00% | -265.7K shares | -8.75M | $47.95 | 0 |
| Q3 2021 | call | Increase | +279.57% | 195.7K shares | 4.33M | $32.96 | 265.7K |
| Q3 2021 | share | Increase | +900.00% | 90K shares | 2.66M | $32.96 | 100K |
| Q3 2021 | put | Increase | +384.36% | 231K shares | 5.79M | $32.96 | 291.1K |
| Q2 2021 | share | Increase | 0.00% | 10K shares | 632K | $63.2 | 10K |
| Q2 2021 | put | Increase | 0.00% | 60.1K shares | 3.79M | $63.2 | 60.1K |
| Q2 2021 | call | Increase | +351.61% | 54.5K shares | 3.75M | $63.2 | 70K |
| Q1 2021 | call | Increase | 0.00% | 15.5K shares | 665K | $42.91 | 15.5K |
| Q4 2020 | call | Decrease | -100.00% | -15K shares | -453K | $57.2 | 0 |
| Q4 2020 | put | Decrease | -100.00% | -15K shares | -453K | $57.2 | 0 |
| Q3 2020 | put | Increase | 0.00% | 15K shares | 453K | $30.17 | 15K |
| Q3 2020 | call | Increase | 0.00% | 15K shares | 453K | $30.17 | 15K |